Sentinels / Actor desk
Sun Pharmaceuticals On
organization · Registry status: unverified
1a2e9717-5003-5aee-980e-6cdf12c4df3f
Evidence, not intent.
Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.
No claim of complete coverage or live monitoring.
Observation window
UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.
Recent observations / timeline
The source record
200 distinct events shown, newest first. More matches exist; narrow the dates to inspect beyond the latest 200. Headlines may be generated summaries; inspect the source before repeating a claim.
Targeted News Service
newjerseytelegraph.com: Abu Dhabi, Abu Dhabi, Abu Dhabi (crisislex c03 wellbeing health, crisislex c03 wellbeing health)
hartfordbusiness.com: Javier Rodriguez, Frank Yocca, Richard Steinhart (tax fncact principal, wb 1921 private sector development)
Santhera Pharmaceuticals CFO on AGAMREE growth in 2026 - One2One Investor Forum
Status Update: Schiaparelli boutique opening at South Coast Plaza
Vitamin D Deficiency Affects 73% of Pakistanis Despite Abundant Sunshine - Pakistan Observer
CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Can a Gene Expression Test Guide Atopic Dermatitis Therapy Selection? | HCPLive
ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru
ADARx Pharmaceuticals, Inc. (NASDAQ:ADRX) Shares Shorted: Short Interest Up 63.6% in October
Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
Good bacteria, broader choice: SA probiotics brands are differentiating their offerings - Insight Survey
Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) Sees Significant Increase in Short Interest
econotimes.com: Eric Hughes, Teva Pharmaceuticals, Teva Pharmaceutical Industries Ltd (crisislex c07 safety, movement general)
Eton Announces New Program For Mecasermin In Epileptic Spasms; Phase 2 Planned For Q1 '27
Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
Brise Pharmaceuticals Announces Global License Agreement with AbbVie to Advance the Next-Generation of Migraine Therapies
tennesseedaily.com: Abu Dhabi, Abu Dhabi, Abu Dhabi (tax disease diseases, tax fncact founder)
The HCPFive: Top News for Healthcare Providers from the Week of 10/25 | HCPLive
Granules India Ltd reports Q2, H1 FY27 results
Eton Announces New Development Program To Evaluate Mecasermin Injection
CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical ...
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
Reviewing Ionis Pharmaceuticals (NASDAQ:IONS) & Pluri (NASDAQ:PLUR)
Olema Pharmaceuticals (OLMA) Expected to Announce Earnings on Monday
Stock Market Today Updates: Sensex surges 1,233 pts, Nifty ends above 23,400; Reliance, Tata Steel top gainers
5,421 Alnylam Pharmaceuticals, Inc. $ALNY Shares Acquired by ProShare Advisors LLC
Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation
Analyzing InMed Pharmaceuticals (NASDAQ:INM) and BioAge Labs (NASDAQ:BIOA)
Lynk Pharmaceuticals Announces Commercialization Collaboration with Simcere for Zemprocitinib in Dermatology Indications, Further Expanding Product Commercialization Footprint
Hydralyte revealed as brand behind ‘Don’t Let the Dryness Get You’ horror stunt ahead of new ‘Here For It’ platform via FbF
Lynk Pharmaceuticals Announces Commercialization Collaboration with Simcere for Zemprocitinib in Dermatology Indications, Further Expanding Product Commercialization Footprint
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stock Has Consensus Price Target of $100.86
Markets open higher as AI selloff boosts anti-tech trade; Reliance, Tata Steel lead gains
Sun Pharma slides nearly 2% as Ilumya concerns weigh on analyst estimates
Galmed Pharmaceuticals Ltd. (NASDAQ:EOCN) Sees Significant Decline in Short Interest
Aurinia (NASDAQ: AUPH) raises revenue outlook but third-quarter profit stays flat
Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) Sees Significant Growth in Short Interest
Pacira BioSciences, Inc. (NASDAQ:PCRX) Stock Short Interest Report for October
FDA approves new preservative-free ketamine, but hospitals still face a shortage first recorded in 2018
aninews.in: Narcotics Control Bureau, National Narcotics Helpline, Competent Authority (seize, epu economy historic)
Accretion Pharmaceuticals Ltd Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27
Financial Contrast: Tango Therapeutics (NASDAQ:TNGX) vs. Inovio Pharmaceuticals (NASDAQ:INO)
Head-To-Head Contrast: Cyclacel Pharmaceuticals (NASDAQ:BGMS) & Ferguson (NYSE:FERG)
Ten November 2026 Class Action Settlement deadlines cluster in roundup - El-Balad.com
Nasdaq 100 本周动向（10-31-2026) - 博客 | 文学城
Details of specialised industrial clusters for pharma and medical devices announced
TNF Pharmaceuticals (NASDAQ:TNFA) Shares Down 3.4% – Here’s What Happened
Critical Contrast: Inovio Pharmaceuticals (NASDAQ:INO) & Shattuck Labs (NASDAQ:STTK)
indiankanoon.org: Pallulabid Ahmad Arimutta, Mihir Rajesh Shah, Jagwinder Singh (wb 696 public sector management, wb 840 justice)
indiankanoon.org: Yashpal Dhir, Yashpal Dhir, Shailesh Kumar Davey (affect, affect)
NRx Pharmaceuticals Wins FDA Approval for Preservative-Free Ketamine Injection
Medexus Eyes $175M GRAFAPEX Opportunity as Transplant Drug Gains Traction
Research Analysts’ Downgrades for October 31st (ABEV, ABR, AFYA, AIT, AKR, AMD, AMKR, AMTM, ANIX, ANL)
Equities Research Analysts’ Upgrades for October 31st (AAMI, ABCL, ACCO, ADM, AGYS, AIN, AM, AMOD, AMRN, AMSF)
Indivior (NASDAQ:INDV) & Zevra Therapeutics (NASDAQ:ZVRA) Financial Review
Stock Traders Purchase High Volume of Call Options on Bausch Health Cos (NYSE:BHC)
Head to Head Comparison: Indivior (NASDAQ:INDV) and Palisade Bio (NASDAQ:PALI)
Bausch + Lomb (NYSE:BLCO) & Nuwellis (NASDAQ:NUWE) Head-To-Head Analysis
Head-To-Head Survey: Baxter International (NYSE:BAX) and LogicMark (OTCMKTS:LGMKD)
ACADIA Pharmaceuticals (NASDAQ:ACAD) EVP Mark Schneyer Sells 3,321 Shares of Company Stock
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock Has Average Price Target of $70.14 According to Brokerages
Life-Saving Medicines Out of Reach as High Prices Crush Bangladeshis
morningstar.com: Josh Beckerman, Josh Beckerman, Inovio Pharmaceuticals (medical, epu cats regulation)
Advances in Cancer Care Are Moving Closer to Home - Shelbyville Times-Gazette
HBV Functional Cure With Bepirovirsen: Platelet, ALT, Kidney Monitoring | HCPLive
Faron Pharmaceuticals Oy (LON:FARN) Reaches New 52-Week Low – Should You Sell?
What Phase 2 Nemolizumab Data Show in Children 2-11 With Atopic Dermatitis | HCPLive
morningstar.com: Bank Bradesco, Bank Bradesco, Hayward Holdings (wb 696 public sector management, wb 696 public sector management)
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sabirnetug Misses Primary Endpoint in Phase 2 Alzheimer Disease Trial | Psychiatric Times
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thousands of Bottles of Blood Pressure Drugs Recalled Across US
Aurinia Skids on Results
bostonglobe.com: Steve Difillippo, Barbara Kopple, Ray Stata (media social, tax fncact professor)
Mitapivat PDUFA Date for Sickle Cell Disease Extended to February 2027 | HCPLive
CMMB Celebrates New Distribution Center at the Brethren Service Center with Ribbon-Cutting Ceremony
Weekly Buzz: ABBV, PFE Win FDA Nod; ARTV Slashes Jobs; DAVI, SGRY Strike Deals
IOL Chemicals and Pharmaceuticals Ltd Records Highest-Ever Quarterly Revenue, EBITDA & PAT
Q2 Results 30th Oct Highlights: GAIL, IOC, Sun Pharma, Aditya Birla, BOB, Aether, Smartworks Q2 PAT rise, Zee Entertainment con. PAT declines, Dixon's profit fall, Reliance, Jio Platforms, BEL, GE Vernova, Lodha, Delhivery, NTPC Green to announce Q2 results
US stock market crash today: Why are Dow Jones, Nasdaq and S&P 500 falling? Intel, Amazon, Nvidia and AMD stocks slide
FDA Extends Agios' Mitapivat Sickle Cell Disease Review; New PDUFA Date Set; Stock Down
Exelixis (EXEL) Q3 2026 Earnings Call Transcript - AOL
Supernus (SUPN) Q3 2026 Earnings Call Transcript | The Motley Fool
timesca.com: Abdulkadir Uralo, Tayyip Erdo, Nobel Pharmaceuticals (crisislex c04 logistics transport, crisislex c04 logistics transport)
Acumen Halts Sabirnetug Development After Phase 2 Trial Miss
Agios Gets New FDA Goal Date For Mitapivat In Sickle Cell Disease
NRx Pharmaceuticals Secures FDA Nod For Preservative-Free Ketamine Ahead Of Target Date; Stock Up
seekingalpha.com: Agios Pharmaceuticals (epu cats healthcare, epu cats healthcare)
Total Voting Rights | Company Announcement | Investegate
Sun Pharma posts lower quarterly profit on one-time acquisition-related charge
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases
ABCs in Dermatology: Rethinking JAK Inhibitor Safety in Atopic Dermatitis | HCPLive
NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA
Syndax Announces Participation in November Investor Conferences
mykeystrokes.com: Froma Harrop, Warren Buffett Berkshire Hathaway, Ackman Pershing Square (tax disease meningitis, ungp healthcare)
AstraZeneca results: 9M and Q3 2026
Sun Pharma's Q2 profit drops 36 pc to Rs 1,989 crore on one-time loss
moneycontrol.com: Sun Pharma, Sun Pharma, Sun Pharma (tax fncact managing director, tax disease arthritis)
Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional charges
HHS Grants Enforcement Discretion for Six Peptides in 503A Compounding Pharmacies
Lyme vaccine showed about 74% efficacy—but protection was measured only after the fourth dose and a second tick season
orissadiary.com: Munjal Patel, Lincoln Pharmaceuticals Limited, Lincoln Pharmaceuticals Ltd (science, soc innovation)
Recce Pharmaceuticals advances Phase 3 program and strengthens commercial pathway in September quarter
Recce’s R327G gains commercial pathway with Arrotex - ICYMI
indiankanoon.org: Brajesh Kumar, Ravi Kumar, Vikash Kumar (wb 2453 organized crime, wb 2453 organized crime)
Five By Five Global Rebrands To FbF
Five by Five Global rebrands as FbF as the indie agency enters its next phase of growth
Supernus expands Ms. Represented campaign with help from Olympian Chloe Kim
newswiretoday.com: Toichi Takino, Japan Society Of Pain Clinicians, Clarivate Plc (tax disease chronic pain, tax disease chronic pain)
newswiretoday.com: Toichi Takino, Pharmaceuticals Basel, Society Of Interstitial Cystitis Of Japan (tax disease fibromyalgia, tax disease fibromyalgia)
sydneysun.com: Munjal Patel, Lincoln Pharmaceuticals Ltd, Lincoln Pharmaceuticals Limited (env solar, env solar)
After 30 Years, FDA Approves First-Ever Drug For a Rare Neurological Disorder
Xenon Reports Promising Pain Data, Targets Phase 2 Trials For Two Drug Candidates
indiagazette.com: Munjal Patel, Lincoln Pharmaceuticals Ltd, Lincoln Pharmaceuticals Limited (wb 525 renewable energy, wb 528 solar energy)
australiannews.net: Munjal Patel, Lincoln Pharmaceuticals Ltd, Lincoln Pharmaceuticals Limited (epu economy historic, science)
Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52% Y-o-Y
Lincoln Pharmaceuticals Ltd Reports Consolidated Net Profit of Rs. 57.50 crore in H1 FY27, growth of 20.52% Y-o-Y
Alnylam (ALNY) Q3 2026 Earnings Call Transcript | The Motley Fool
seekingalpha.com: Alnylam Pharmaceuticals (epu economy historic, epu economy historic)
The molecule was fine. The moment wasn’t.
Trump administration will allow pharmacies to make popular peptides
Senores Pharma Posts Record Q2 Revenue & EBITDA
aninews.in: Munjal Patel, Lincoln Pharmaceuticals Ltd, Lincoln Pharmaceuticals Limited (wb 1614 nutritional programs, wb 1614 nutritional programs)
Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute Pain
Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
Alnylam Q3 2026: The $1.9B Tax Windfall Behind a Huge EPS Beat
Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute Pain
Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute Pain
Alnylam Pharmaceuticals (ALNY) Stock Price, News & Analysis | 24/7 Wall St.
Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute Pain
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute Pain
Corvus Pharmaceuticals to Provide Business Update and Third Quarter 2026 Financial Results on November 5, 2026
Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics
CNIPA upholds validity of pharmaceutical use patent for crisaborole
Shweta Rai of Bayer Pharmaceuticals is looking to expand the portfolio - BusinessToday
Senores Pharmaceuticals Ltd announces Robust Financial & Operational Performance in Q2 and H1 FY27
Stock Market Highlights, Oct 29: Sensex settles 905 pts higher, Nifty ends above 22,900; Adani Ports, Kotak Bank top gainers
Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Opus Genetics Appoints Dr. Andrew Murphy as Chief Scientific Officer and Jamie Lynne Hart as Executive Director, Executive Operations
Ligand Reports Third Quarter 2026 Financial Results
A Father's Search for Answers Leads to Astrosalva Therapeutics, a New Biotech for Alexander Disease and cALD
Biogen Inc.: Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026
Beximco Pharma recommends 60% cash dividend, highest since 2020
Notification of Preliminary Results and AGM | Company Announcement | Investegate
Neuren Pharmaceuticals Shares Jump 6% as Investors Eye Japan Trial Readout and European Launch of Rett Drug
Sheikh Nahyan honours UAE healthcare leaders at Sixth Annual Health Awards 2026
Idorsia and SPV investors partner to unlock the blockbuster potential of TRYVIO/JERAYGO with a targeted launch in specialists
Idorsia Pharmaceuticals Ltd: Idorsia reports accelerating QUVIVIQ growth, advances key value drivers, and reaffirms full-year financial guidance
Idorsia reports accelerating QUVIVIQ growth, advances key value drivers, and reaffirms full-year financial guidance
Vanda (VNDA) Q3 2026 Earnings Call Transcript | The Motley Fool
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides | WNYC
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
indiankanoon.org: Divyanshu Rai, Shah Namkeen, Shah Namkeen (discrimination, ungp freedom from discrimination)
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Interact joins Anthropic’s Cyber Verification Program to strengthen enterprise intranet security with Claude Mythos 5.1
Trump administration will allow pharmacies to make popular peptides
Interact joins Anthropic’s Cyber Verification Program to strengthen enterprise intranet security with Claude Mythos 5.1
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Trump administration will allow pharmacies to make popular peptides
Signals to inspect
Anomalies
Latest 10 in the selected window (up to 10). Detector output, not verified conclusions.
New connection: 2 previously unseen co-actor(s) detected (known network: 1318)
New connection: 7 previously unseen co-actor(s) detected (known network: 1311)
New connection: 46 previously unseen co-actor(s) detected (known network: 1281)
Tone shift: score -6.0 deviates 2.9σ from baseline mean 0.0 (stddev 2.06)
New connection: 3 previously unseen co-actor(s) detected (known network: 1278)
Coordination signal: co-actor 0053465d-9438-5e60-8a77-792b862a7b6d appeared in 3 of 5 window events (60%)
New connection: 2 previously unseen co-actor(s) detected (known network: 1276)
New connection: 5 previously unseen co-actor(s) detected (known network: 1271)
Volume spike: 33 events in window (6.6x baseline of 5.0 expected)
Narrative context
Unresolved threads
Latest 20 at most, across all dates. Stored narratives require human review.
Stored connections
Relationships
Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.
- Sun Pharmaceuticals On→ co mention →Nasdaq2094 evidence records
- Sun Pharmaceuticals On→ co mention →United States Senate1833 evidence records
- Drug Enforcement Administration→ co mention →Sun Pharmaceuticals On1186 evidence records
- Sun Pharmaceuticals On→ co mention →Securities and Exchange Commission990 evidence records
- Sun Pharmaceuticals On→ co mention →News Ratings For Amylyx Pharmaceuticals Daily835 evidence records
- Sun Pharmaceuticals On→ co mention →Terms Of Service544 evidence records
- Sun Pharmaceuticals On→ co mention →Nrx Pharmaceuticals Price Performance505 evidence records
- Sun Pharmaceuticals On→ co mention →Eli Lilly454 evidence records
- Sun Pharmaceuticals On→ co mention →Sino Biopharmaceutical Company Profile443 evidence records
- Prnewswire Telix Pharmaceuticals Limited→ co mention →Sun Pharmaceuticals On384 evidence records
- Sun Pharmaceuticals On→ co mention →Facebook359 evidence records
- Sun Pharmaceuticals On→ co mention →Linkedin326 evidence records
- Sun Pharmaceuticals On→ co mention →Astrazeneca318 evidence records
- Sun Pharmaceuticals On→ co mention →Pfizer292 evidence records
- Sun Pharmaceuticals On→ co mention →Australian Stock Exchange On271 evidence records
- Sun Pharmaceuticals On→ co mention →Geode Capital Management268 evidence records
- Sun Pharmaceuticals On→ co mention →Bristol Myers Squibb266 evidence records
- Sun Pharmaceuticals On→ co mention →Telomir Pharmaceuticals Trading Down252 evidence records
- Sun Pharmaceuticals On→ co mention →Donald Trump245 evidence records
- Sun Pharmaceuticals On→ co mention →Novo Nordisk228 evidence records
- Sun Pharmaceuticals On→ co mention →Citigroup222 evidence records
- Sun Pharmaceuticals On→ co mention →Corporate Communications Department220 evidence records
- Sun Pharmaceuticals On→ co mention →Armen Kasparian200 evidence records
- Sun Pharmaceuticals On→ co mention →Morgan Stanley200 evidence records
- Sun Pharmaceuticals On→ co mention →Anime News Network190 evidence records
- Sun Pharmaceuticals On→ co mention →International Law185 evidence records
- Sun Pharmaceuticals On→ co mention →Barclays183 evidence records
- Sun Pharmaceuticals On→ co mention →JPMorgan Chase183 evidence records
- Sun Pharmaceuticals On→ co mention →Nvidia179 evidence records
- Amgen→ co mention →Sun Pharmaceuticals On177 evidence records
- Sun Pharmaceuticals On→ co mention →Zacks Research175 evidence records
- Sun Pharmaceuticals On→ co mention →Novartis175 evidence records
- Sun Pharmaceuticals On→ co mention →More Teva Pharmaceutical Industries News173 evidence records
- Sun Pharmaceuticals On→ co mention →Federal Reserve173 evidence records
- Sun Pharmaceuticals On→ co mention →Quarter For Recursion Pharmaceuticals171 evidence records
- Sun Pharmaceuticals On→ co mention →Cipla171 evidence records
- Sun Pharmaceuticals On→ co mention →Lucy Williamson171 evidence records
- Sun Pharmaceuticals On→ co mention →Analyst Recommendations For Alamo Group170 evidence records
- Sun Pharmaceuticals On→ co mention →Goldman Sachs Group Inc169 evidence records
- Sun Pharmaceuticals On→ co mention →Ovid Therapeutics Inc161 evidence records
- Sun Pharmaceuticals On→ co mention →National Institutes Of Pharmaceutical Education157 evidence records
- Sun Pharmaceuticals On→ co mention →Fosun Pharma151 evidence records
- Sun Pharmaceuticals On→ co mention →Securities Class Action Services147 evidence records
- Sun Pharmaceuticals On→ co mention →York To Royal Bank146 evidence records
- Sun Pharmaceuticals On→ co mention →Institutional Investors Weigh In On Bluerock Homes144 evidence records
- Sun Pharmaceuticals On→ co mention →Natco Pharma142 evidence records
- Sun Pharmaceuticals On→ co mention →Levi Korsinsky142 evidence records
- Sun Pharmaceuticals On→ co mention →European Union142 evidence records
- Sun Pharmaceuticals On→ co mention →Hedge Funds Weigh In On Nrx Pharmaceuticals141 evidence records
- Sun Pharmaceuticals On→ co mention →Eboog Johnson135 evidence records